findmyKOL
Clinical trialNCT03816956CompletedPhase 3Interventional

Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301

SponsorAridis Pharmaceuticals, Inc.Enrollment174Infection, BacterialLung InfectionPneumonia, Ventilator-AssociatedStaphylococcus Aureus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

AR-301 is being evaluated as an adjunctive treatment of ventilator-associated pneumonia (VAP) due to Staphylococcus aureus (S. aureus) in combination with standard of care (SOC) antibiotic therapy in patients with confirmed S. aureus infection.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belarus
  • Blr-06

    Grodno, Belarus

  • Blr-04

    Homyel, Belarus

  • Blr-01

    Minsk, Belarus

Belgium
  • Bel-01

    Lodelinsart, Belgium

  • Bel-05

    Ottignies, Belgium

Brazil
  • Bra-04

    Curitiba, Brazil

  • Bra-08

    Curitiba, Brazil

China
  • Chn-09

    Guangzhou, Guangdong, China

Estonia
  • Est-01

    Tallinn, Estonia

France
  • Fra-02

    Strasbourg, Cedex, France

  • Fra-18

    Brive-la-Gaillarde, France

  • Fra-10

    Bron, France

  • Fra-05

    La Roche-sur-Yon, France

  • Fra-04

    Limoges, France

  • Fra-01

    Nantes, France

  • Fra-16

    Orléans, France

  • Fra-11

    Rennes, France

  • Fra-13

    Trévenans, France

Georgia
  • Geo-06

    Gori, Georgia

  • Geo-01

    Kutaisi, Georgia

  • Geo-03

    Kutaisi, Georgia

  • Geo-04

    Kutaisi, Georgia

  • Geo-10

    Kutaisi, Georgia

  • Geo-02

    Tbilisi, Georgia

  • Geo-07

    Tbilisi, Georgia

  • Geo-09

    Tbilisi, Georgia

Israel
  • Isr-04

    Haifa, Israel

  • Isr-01

    Ramat Gan, Israel

Latvia
  • Lva-02

    Riga, Latvia

Mexico
  • Mex-07

    Guadalajara, Jalisco, Mexico

Russia
  • Rus-18

    Arkhangelsk, Russia

  • Rus-11

    Chelyabinsk, Russia

  • Rus-01

    Krasnoyarsk, Russia

  • Rus-04

    Novosibirsk, Russia

  • Rus-02

    Saint Petersburg, Russia

  • Rus-10

    Smolensk, Russia

  • Rus-16

    Zhukovskiy, Russia

South Africa
  • Zaf-09

    Johannesburg, South Africa

Spain
  • Esp-01

    Madrid, Spain

Turkey (Türkiye)
  • Tur-06

    Istanbul, Turkey (Türkiye)

5 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AR-301
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 May 2019
Primary completion
28 Oct 2022
Completion
28 Oct 2022
Last update posted
6 Jul 2023
Registered enrollment
174
Registry id
NCT03816956
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.